Disclosed herein is a method for making compounds that are useful as caspase inhibitor prodrugs of formula I:
1
wherein R
1
is an optionally substituted group selected from an aliphatic group, aralkyl group, heterocyclylalkyl group or aryl group, and R
2
is preferably a P
2
-P
4
moiety of a caspase inhibitor. Key intermediates include the azidolactones III and VIII:
2
本文揭示了一种制备化合物的方法,这些化合物可作为式I中的caspase
抑制剂前药使用:其中R1是从脂肪族群、芳基烷基群、杂环烷基群或芳基群中选择的可选取代基团,而R2最好是caspase
抑制剂的P2-P4基团。关键中间体包括azidolactones III和VIII。